Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03684057 · ClinicalTrials.gov registry record · NA

Targeting Worry to Improve Sleep

A NA study, sponsored by Brown University.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT03684057: Completed NA study, sponsored by Brown University.

NCT03684057 is a NA study that has completed, run by Brown University. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03684057, a NA study, has completed, sponsored by Brown University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The purpose of this study is to test an app-based mindfulness training program for worry to see if it can help individuals decrease worry and improve sleep.

Primary Outcome

5 questions from the 29-item Patient-Reported Outcomes Measurement Information System (PROMIS-29) pertaining to anxiety and sleep will be used to assess worry-related sleep disturbances over the past 7 days. These questions are on a 5-point Likert scale where 1 is "Not at all" and 5 is "Very much". Scores can range from 5 to 25 and higher scores indicate a worse outcome.

Interventions

  • BEHAVIORAL App-Delivered Mindfulness Training (MT)

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2019-07-25
Est. Completion 2020-02-26
Phase NA
Brown University

231 total trials

What the finished NCT03684057 record still lists

NCT03684057 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which App-Delivered Mindfulness Training (MT) is the first listed.

NCT03684057 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03684057 about?

NCT03684057 is a clinical study titled "Targeting Worry to Improve Sleep". The purpose of this study is to test an app-based mindfulness training program for worry to see if it can help individuals decrease worry and improve sleep.

What is the current status of trial NCT03684057?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-07-25. Estimated completion is 2020-02-26.

What interventions are being tested in trial NCT03684057?

The interventions under investigation include: App-Delivered Mindfulness Training (MT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03684057?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03684057's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03684057, the US trial registry maintained by the National Library of Medicine. NCT03684057 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.